To characterize the cardiovascular disease (CVD) profile of individuals aged 80 and older in rural South Africa. DESIGN: First wave of population-based longitudinal cohort. SETTING: Agincourt subdistrict (Mpumalanga Province) in rural South Africa. PARTICIPANTS: Adults residents (N = 5,059). MEASUREMENTS: In-person interviews were conducted to obtain social, behavioral, economic, and clinical data. Prevalence of hypertension, diabetes, dyslipidemia, high waist-to-hip ratio, overweight and obesity, high-risk highsensitivity C-reactive protein, smoking, stroke, myocardial infarction, angina pectoris, and heart failure in individuals younger than 65, aged 65 to 79, and aged 80 and older were compared. Associations between self-reported treatments and determinants of hypertension treatment in those aged 80 and older were assessed using multivariable regression. RESULTS: Of 5,059 individuals included, 549 (10.8%) were aged 80 and older, and their CVD prevalence was 17.9% (stroke 3.8%, myocardial infarction 0.5%, angina pectoris 13.5%, heart failure 0.7%). Hypertension prevalence in this group was 73.8%, and along with angina pectoris, it increased with age (p<.001), whereas overweight and obesity (46.4%), dyslipidemia (39.1%), and smoking prevalences (3.1%) decreased (p<.001). Hypertension treatment was significantly associated with being aged 80 and older (odds ratio (OR)=1.48; 95% confidence interval (CI)=1.14-1.92, p=.003). Male sex (OR=0.73, 95% CI=0.66-0.88, p=.001), being an immigrant (OR=0.80, 95% CI=0.65-0.98; p=.03), higher socioeconomic status (OR=1.28, 95% CI=1.06-1.53, p=.009), and higher depression score (OR=1.12, 95% CI=1.05-1.19, p<.001) were associated with hypertension treatment in those aged 80 and older. CONCLUSION: This is the first study to characterize the CVD profile of individuals aged 80 and older in subSaharan Africa and provides baseline data for comparison with future studies in this rapidly growing age group.
T he world's population is aging rapidly, and adults aged 65 and older are starting to outnumber young adults for the first time. 1 Although the focus for much research into health service delivery for aging populations has been in highincome countries, attention is broadening to include lowerand middle-income countries. Populations in middle-income countries, in particular, are generally aging at a much faster rate than those in high-income countries. 2 Subsequently, chronic diseases, including cardiovascular diseases (CVD), are a major burden of morbidity and mortality in low-resource settings, including in sub-Saharan Africa (SSA). [3] [4] [5] The fastest-growing segment of the total population is adults aged 80 and older. Their global growth rate is twice that of those aged 65 and older and almost 4 times that of the total population. Worldwide, the population of adults aged 80 and older is projected to more than triple between 2015 and 2050, from 126.5 million to 446.6 million. 6 This increase will present a major challenge for health and social care systems if patterns in high-income countries are replicated in lower-and middle-income countries, with this age group having the highest burden of multimorbidity, the greatest prevalence of frailty syndromes, and subsequently the greatest need for health and social care. 7 Understanding patterns of disease in the oldest segment of the population will help healthcare systems to predict future noncommunicable disease needs, in part by showing how disease burden might evolve as populations age. It will also assist in determining health and social service needs, along with effective services delivery, yet little consideration has been given to issues of old age and CVD in South Africa, particularly for the oldest adults, as the lack of literature on CVD and its risk factors in this growing segment of the population in SSA reflects.
Driven by this lack of information, we assessed the oldest participants from the Health and Aging in Africa: Longitudinal Studies of INDEPTH Communities (HAALSI), aiming to compare cardiovascular risk factors and CVD prevalence of participants younger than 65, aged 65 to 79, and aged 80 and older; identify associations between self-reported treatments and being aged 80 and older; and explore predictors of CVD management in this age group.
METHODS
The HAALSI cohort is based in the Agincourt Health and socio-Demographic Surveillance System (HDSS) site, a subdistrict of rural Mpumalanga Province comprising approximately 116,000 people living in 21,000 households and 31 villages in an area of approximately 450 km². The Agincourt HDSS covers a border region of rural South Africa adjacent to southern Mozambique. 8 Five thousand eight hundred ninety persons were identified for recruitment from the HDSS database using random sampling based on the 2013 Agincourt census data. All adults aged 40 and older who had permanently resided in the Agincourt subdistrict for at least 1 year before the 2013 census update were eligible. The baseline wave of data collection for HAALSI was conducted in 2015 in a cohort of 5,059 men and women aged 40 and older. Detailed descriptions of the cohort and data collection procedures have been published elsewhere [9] [10] [11] and are included in Supplementary Appendix S1.
Cardiovascular risk factor definitions
Hypertension was defined as mean systolic blood pressure of 140 mmHg or greater, mean diastolic blood pressure of 90 mmHg or greater, 12 or self-reported treatment. Diabetes was defined as a self-reported history, a fasting blood glucose level (FBG) of 7.0 mmol/L or greater, a random blood glucose level (RBG) of 11.1 mmol/L or greater, 13 or self-reported treatment. Dyslipidemia was defined as a self-reported history, measured total cholesterol level greater than 5 mmol/L, low-density lipoprotein cholesterol greater than 3 mmol/L, high-density lipoprotein cholesterol less than 1.2 mmol/L, triglycerides greater than 1.7 mmol/L, 14 or self-reported treatment. Waist-to-hip ratio was classified as high if greater than 0.90 in men and greater than 0.85 in women. 15 Body mass index was used to categorize subjects as overweight (≥25.0 kg/m 2 using World Health Organization cutoffs.
16 Highsensitivity C-reactive protein (hs-CRP) was categorized as low ( < 1 mg/L), intermediate (1-3 mg/L), or high ( > 3 mg/L) risk. 17, 18 Smoking was defined according to self-reported current smoking status.
CVD definitions
CVD events were assessed using self-reported history of myocardial infarction (MI), stroke, heart failure (HF), and angina pectoris (defined according to self-report or applying the globally validated Rose criteria questionnaire). 19 CVD was defined as any report of stroke, MI, angina pectoris, or HF.
Age stratification
Individuals were stratified into three age groups (<65, 65-79, ≥ 80) to assess the effect of age on CVD prevalence and risk factors.
Other covariates
Human immunodeficiency virus (HIV)-positive status was defined as a self-reported history of being informed of the condition by a health professional or a positive result on assay analysis. Socioeconomic status (SES) is a composite, constructed variable incorporating measures of traditional and modern wealth using methodology created for demographic health surveys and divided into quintiles. The first 3 quintiles were classified as low SES and the last 2 quintiles as high SES. 20, 21 Immigrants, mostly Mozambican, were defined as participants born outside South Africa. Illiteracy was defined as self-reported inability to read or write. Depression was scored using the 8-item Center for Epidemiologic Studies Depression Scale (CES-D-8), with higher scores indicating higher burdens of depressive symptoms. 22 The total number of social contacts was assessed according to self-report based on the past 6 months' contacts, ranging from 0-7 and reported as a continuous variable.
Analyses
All analyses were conducted using STATA version 14 (STATA Corp, College Station, TX). Normally distributed continuous variables were expressed as means±stan-dard deviations, and categorical variables were expressed as absolute numbers and percentages. The Wilcoxon signedrank test was used to compare the variables according to age, and results are presented as p-values for trends. A multivariable logistic regression model was built to identify which CVD/risk factor treatments were associated with being aged 80 and older. The model was adjusted for hypertension, diabetes, dyslipidemia, smoking, overweight and obesity, high waist-to-hip ratio, high-risk hs-CRP, angina pectoris, MI, stroke, HF, and HIV status. A second model was built to identify variables associated with receiving hypertension treatment for participants aged 80 and older, not focusing on age interactions because only participants aged 80 and older were include in the model. Predictors used in the regression model included those previously assessed in this cohort (sex, HIV status, SES, immigration status, illiteracy) 23 , along with depressive symptoms (CES-D-8) and total number of social contacts. The model was adjusted for diabetes, dyslipidemia, smoking, overweight and obesity, high waist-to-hip ratio, high-risk hs-CRP, angina pectoris, MI, stroke, and HF. The results are presented using odds ratios (ORs) and 95% confidence intervals (CIs). An alpha level of .05 was used to determine statistical significance in all analyses.
RESULTS
Of the 5,890 persons identified for recruitment who were alive and residing in the study area, 85.9% (5,059) agreed to be interviewed, 7.3% (430) refused to participate, 6.0% (354) could not be located, and 0.8% (47) were unable to participate. The population characteristics of those aged 80 and older (n=549, 10.8%) are compared with the characteristics of those aged 65 to 79 and younger than 65 in Table 1 . Mean systolic blood pressure increased, and diastolic blood pressure and body mass index decreased, with increasing age category. The proportions of men and HIVpositive participants were lower in those aged 80 and older than in the other age groups.
Cardiovascular risk factors are presented according to age group in Table 2 , and CVD prevalence is presented according to age group in Figure 1 . Hypertension prevalence was greater in older participants, and dyslipidemia, overweight and obesity, and smoking were lower. Prevalence of any CVD and of angina pectoris individually increased with age. For stroke, the highest prevalence was found in the group aged 65 to 79.
The distribution of treatment for CVD and cardiovascular risk factors is shown in Table 3 . The only statistically significant difference in treatment rates between the 3 age groups was found for hypertension (p<.001), with treatment rates highest in those aged 65 to 79.
To identify CVD/risk factor treatments independently associated with being aged 80 and older, we conducted a multivariable regression that showed that only treatment for hypertension was independently associated with being aged 80 and older (OR=1.48, 95% CI=1.14-1.92, p=.003); diabetes, dyslipidemia, angina pectoris, MI, stroke, and HF treatments were not associated (Supplementary Table S1 ).
A second multivariable regression was conducted using hypertension treatment as the outcome (Table 4) 
DISCUSSION
There was a higher proportion of participants aged 80 and older in this baseline wave of HAALSI than in the African continent pattern. 1 These oldest participants were more likely to be female and HIV negative than the other age groups. Hypertension and angina pectoris prevalence increased with age, and dyslipidemia, overweight and obesity and tobacco smoking prevalence decreased. The only cardiovascular condition for which treatment was independently associated with being aged 80 and older was hypertension, with men and immigrants aged 80 and older having an inverse association with hypertension treatment (being less likely to receive treatment), whereas higher SES and higher depression scores were positively associated with hypertension treatment. Assessing CVD in older people from South Africa might seem to be a paradoxical undertaking because life expectancy is 57.2 in the country, 24 but life expectancy in the region is increasing rapidly, and this epidemiological transition will lead to enormous growth in the proportion of the population reaching old age and huge increases in absolute numbers of those surviving to old age. It is therefore necessary to understand the burden of disease in old age to allow health systems to plan for this transition at the country and continental levels. 25 As expected, individuals aged 80 and older were more likely to be female 1 and HIV negative than the overall cohort. 26 Lower infection rates in older participants (who would have been ≥60 in the mid1990s when HIV transmission increased rapidly in the heterosexual population) and shorter life expectancy for HIVpositive individuals, 27 with a low probability of living to 80, can explain this. The survivors therefore represent a cohort with less HIV infection.
The blood pressure patterns found in this study are also consistent with data on older people from observational 28 and intervention studies. 29 Individuals this age usually have higher levels of systolic blood pressure and lower levels of diastolic blood pressure, attributable to arterial stiffening and greater pulse wave velocity. Higher hypertension prevalence in high-income countries, particularly isolated systolic hypertension, 30 is well described in the oldest adults. The 73.8% prevalence of hypertension in the oldest participants in our cohort is similar to results from high-income countries 31, 32 and illustrates a similar increase with age consistent with the pathophysiology of hypertension described above. 31 We also found that the percentage of participants receiving hypertension treatment was higher in participants aged 80 and older than in the rest of the population. This is consistent with a previous analysis of this population that focused on hypertension management and showed a positive association between being older and receiving hypertension treatment. 23 Hypertension is strongly associated with shorter life expectancy, 33 and treatment of carefully selected people aged 80 and older can reduce cardiovascular events and even all-cause mortality. 29 CVD, defined here as any report of angina pectoris, MI, stroke, or HF, was more common in participants aged 80 and older. This was mainly attributed to the higher percentage of angina pectoris in this age group than in the overall population rather than a consistently high percentage of all types of CVD. This may be due to information bias resulting from self-report. It has been shown that assessing CVD in the oldest adults according to self-report underestimates the true prevalence of conditions 34 ; in highincome countries, the prevalence of chronic HF is 5 to 10 times as high as reported here, and previous MI is similarly more common. 35, 36 The only exception is angina pectoris, a condition for which reliable agreement between selfreport by the oldest adults and physician report of CVD has been shown. 34 Nevertheless, angina pectoris was defined according to self-report and the Rose criteria and may be overestimated in this population. This provides another possible explanation for the marked difference between the prevalences of angina pectoris and MI.
Because hypertension is a critical risk factor for stroke, surprisingly few strokes were reported in the oldest old individuals from our study. The higher prevalence in participants aged 65 to 79 may indicate that stroke is underdiagnosed as the population gets older or, alternately, although stroke incidence is high, survival after stroke is short, resulting in a low prevalence. 37 Our findings suggest a healthy survivor effect for some risk factors, represented here by the lower prevalence of such risk factors in the oldest members of the cohort. Smoking and dyslipidemia for instance, were less prevalent with increasing age. For diabetes, prevalence peaked in the group aged 65 to 79 and was lower in those aged 80 and older. These results reinforce the need to examine measured, rather than extrapolated, prevalence in the oldest adults. Further work is required to determine whether these findings are due to truly lower incidence or to differences in the effect of risk factors on the oldest adults.
After multivariable adjustment for multiple risk factors, being male and being an immigrant were previously reported as being associated with worse hypertension management in this population 23 , and this is consistent with our findings in this analysis. Higher SES was found to be directly associated with hypertension treatment in the oldest old individuals, and this result is also consistent with previous findings for this cohort 23 . Depression score and its association with hypertension have not been previously assessed in this cohort, and we are unaware of any studies that have examined this association in very old adults. Prior reports have demonstrated that depressive symptoms are associated with inadequate blood pressure control and complications of hypertension 38, 39 at all ages. Because our results showed that higher depression scores are positively associated with hypertension treatment in this age group, further studies are needed to determine how age is related to depressive symptoms and high blood pressure management.
Despite not being able to assess causality with this baseline data, the innovative aspect of characterizing cardiovascular risk factors and CVD in individuals aged 80 and older living in a region where an epidemiological transition is occurring 40 is an important contribution. Our results will serve as a baseline for future population-based studies in this age group and for a better understanding of aging in SSA. The age profile, poverty, poor infrastructure, and patchy healthcare in the Agincourt area make the results generalizable to many other low-resource areas of SSA. The self-reported nature of disease diagnosis is a potential limitation of our study. This approach can result in incorrect estimations of prevalence, especially for chronic asymptomatic conditions such as hypertension and dyslipidemia. The use of biomarkers and echocardiograms (piloted during the baseline phase) will provide more accurate estimations.
Another potential limitation is the lack of information about past and current treatment regimens for participants. Such information, which will be collected in the follow-up phase through already-established linkages to clinic registers, will provide more accurate data to inform CVD management in this age group.
The assessment of CVD/risk factor prevalence in this age group provides previously undocumented baseline data for South Africa and provides data to guide healthcare systems and policy development for effective clinical management in this rapidly growing population that is far removed from better-resourced public health sector infrastructure. This is the first study to characterize the cardiovascular risk factors and CVD profile of the oldest citizens in SSA. Our results provide baseline data for comparison with planned follow-up of this cohort and future studies in this rapidly growing age group from the region.
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